DocChart
Population Health
Patient panel
Loading the selected patient panel and chart summaries.
Switching panel
Preparing patient rows, flags, problems, medications, and last visit summaries.
Panel size
...
Loading patient records
With open flags
...
Loading review signals
With recent visit
...
Loading visit dates
Accepted chart labels
Human-confirmed labels that stay on the chart after a cohort membership is accepted.
0, active
No accepted chart labels yet. Cohort memberships and review tasks still appear below before anything is accepted.
Cohort memberships
Patient-list membership from saved cohort runs. These are source lists, not task status or accepted chart labels.
1, current
Smoking / Lung Screening review cohort
Chart evidence: Care element: smoking_status never synthetic-demo | Clinical note: SOAP note Diabetes follow-up S: Patient seen for longitudinal primary care follow-up. Reports va...
membership needs review
No review task has been created from this cohort for this patient yet.
Open review tasks
1
New, in review, or accepted tasks
Last visit
2026-01-17
Appointment or derived chart contact
Latest A1c
7.8 %
2026-01-13
Latest BP
124 mmHg / 68 mmHg
2026-01-13
Extracted signals
0
Optional text signals
Chart volume
93
7 notes, 7 reports
A compact view of what needs attention before opening the full imported record.
Review priority
1
active signal
1
0
0
Review these before relying on the imported record clinically.
Review needed
1 open flag
Open clinical review items need status, assignment, or closure.
Active problems
2
Type 2 diabetes mellitus
E11
active
Dyslipidemia
E78.5
active
Active medications
3
Metformin
500mg BID
Ramipril
5mg daily
Rosuvastatin
10mg daily
AI-CDS actions selected from Flags & Tasks. These stay visible on the chart for follow-up.
0, selected
No selected follow-up actions
Select AI-CDS actions from Flags & Tasks to keep them visible on this chart.
Optional text-derived evidence extracted beside the imported chart. Each signal stays traceable to source text.
No extracted signals for this patient
Reprocess an import with text enrichment to attach suggested evidence to this patient record.
Most recent values are summarized here so the timeline can stay readable.
Recent chart, workflow, AI, cohort, and audit events shown in the user's local time.
79, more source rows below
Latest narrative evidence, clipped for scanning.
Recent report headers and excerpts.
Audit view for imported records. Kept collapsed so the working chart remains usable.
cohort_run
Cohort: Smoking / Lung Screening review cohort
completed | Chart evidence: Care element: smoking_status never synthetic-demo | Clinical note: SOAP note Diabetes follow-up S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 132/84, BMI 25.2,... | Clinical note: SOAP note Diabetes follow-up S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 131/83, BMI 24.2,... | Care element: smoking_status never synthetic-demo | probable
alert
Diabetes monitoring due soon
Synthetic alert for testing active cohort and review workflows.
clinical_flag
Synthetic diabetes monitoring review
new | medium | synthetic_longitudinal_data | Longitudinal synthetic data suggests diabetes with recent monitoring possibly due.
appointment
Chronic disease follow-up
completed
note
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 132/84, BMI 25.2, cardiopulmonary exam stable, feet checked when diab
report
Laboratory
Lab panel: HbA1c 7.8%, LDL 3.3 mmol/L, eGFR 81, ACR 1.9. Interpret in clinical context.
note
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 131/83, BMI 24.2, cardiopulmonary exam stable, feet checked when diab
report
Laboratory
Lab panel: HbA1c 7.7%, LDL 3.2 mmol/L, eGFR 80, ACR 1.8. Interpret in clinical context.
appointment
Chronic disease follow-up
completed
appointment
Chronic disease follow-up
completed
note
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 130/82, BMI 23.2, cardiopulmonary exam stable, feet checked when diab
report
Laboratory
Lab panel: HbA1c 7.6%, LDL 3.1 mmol/L, eGFR 79, ACR 1.7. Interpret in clinical context.
appointment
Chronic disease follow-up
completed
appointment
Chronic disease follow-up
completed
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 132/84, BMI 25.2, cardiopulmonary exam stable, feet checked when diabetes present. A: Type 2 diabetes follow-up; risk factors reviewed. P: Review labs, reinforce lifestyle plan, reconcile medications, update immunizations, and arrange follow-up. Clinician review required for any care gap.
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 131/83, BMI 24.2, cardiopulmonary exam stable, feet checked when diabetes present. A: Type 2 diabetes follow-up; risk factors reviewed. P: Review labs, reinforce lifestyle plan, reconcile medications, update immunizations, and arrange follow-up. Clinician review required for any care gap.
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 130/82, BMI 23.2, cardiopulmonary exam stable, feet checked when diabetes present. A: Type 2 diabetes follow-up; risk factors reviewed. P: Review labs, reinforce lifestyle plan, reconcile medications, update immunizations, and arrange follow-up. Clinician review required for any care gap.
SOAP note
S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 129/81, BMI 36.2, cardiopulmonary exam stable, feet checked when diabetes present. A: Type 2 diabetes follow-up; risk factors reviewed. P: Review labs, reinforce lifestyle plan, reconcile medications, update immunizations, and arrange follow-up. Clinician review required for any care gap.
Synthetic diabetes monitoring review
Longitudinal synthetic data suggests diabetes with recent monitoring possibly due.
Laboratory
Lab panel: HbA1c 7.8%, LDL 3.3 mmol/L, eGFR 81, ACR 1.9. Interpret in clinical context.
Laboratory
Lab panel: HbA1c 7.7%, LDL 3.2 mmol/L, eGFR 80, ACR 1.8. Interpret in clinical context.
Laboratory
Lab panel: HbA1c 7.6%, LDL 3.1 mmol/L, eGFR 79, ACR 1.7. Interpret in clinical context.
Laboratory
Lab panel: HbA1c 7.5%, LDL 3.0 mmol/L, eGFR 78, ACR 1.6. Interpret in clinical context.
Laboratory
Hba1c
7.8 %
2026-01-13Fasting Glucose
8.6 mmol/L
2026-01-13Ldl Cholesterol
3.3 mmol/L
2026-01-13Egfr
81 mL/min/1.73m2
2026-01-13Albumin Creatinine Ratio
1.9 mg/mmol
2026-01-13Systolic Bp
Date | Type | Title | Detail |
|---|---|---|---|
cohort_run | Cohort: Smoking / Lung Screening review cohort | completed | Chart evidence: Care element: smoking_status never synthetic-demo | Clinical note: SOAP note Diabetes follow-up S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 132/84, BMI 25.2,... | Clinical note: SOAP note Diabetes follow-up S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 131/83, BMI 24.2,... | Care element: smoking_status never synthetic-demo | probable | |
alert | Diabetes monitoring due soon | Synthetic alert for testing active cohort and review workflows. | |
clinical_flag | Synthetic diabetes monitoring review | new | medium | synthetic_longitudinal_data | Longitudinal synthetic data suggests diabetes with recent monitoring possibly due. | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 132/84, BMI 25.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.8%, LDL 3.3 mmol/L, eGFR 81, ACR 1.9. Interpret in clinical context. | |
care_element | smoking_status | never | |
care_element | diastolic_bp | 68 | |
care_element | egfr | 81 | |
care_element | hba1c | 7.8 | |
care_element | fasting_glucose | 8.6 | |
care_element | ldl_cholesterol | 3.3 | |
care_element | bmi | 29.2 | |
care_element | systolic_bp | 124 | |
care_element | albumin_creatinine_ratio | 1.9 | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 131/83, BMI 24.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.7%, LDL 3.2 mmol/L, eGFR 80, ACR 1.8. Interpret in clinical context. | |
care_element | systolic_bp | 123 | |
care_element | smoking_status | never | |
care_element | bmi | 28.2 | |
care_element | diastolic_bp | 80 | |
care_element | albumin_creatinine_ratio | 1.8 | |
care_element | egfr | 80 | |
care_element | ldl_cholesterol | 3.2 | |
care_element | fasting_glucose | 8.5 | |
care_element | hba1c | 7.7 | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 130/82, BMI 23.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.6%, LDL 3.1 mmol/L, eGFR 79, ACR 1.7. Interpret in clinical context. | |
care_element | systolic_bp | 122 | |
care_element | albumin_creatinine_ratio | 1.7 | |
care_element | egfr | 79 | |
care_element | smoking_status | never | |
care_element | bmi | 27.2 | |
care_element | ldl_cholesterol | 3.1 | |
care_element | hba1c | 7.6 | |
care_element | fasting_glucose | 8.4 | |
care_element | diastolic_bp | 79 | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 129/81, BMI 36.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.5%, LDL 3.0 mmol/L, eGFR 78, ACR 1.6. Interpret in clinical context. | |
care_element | fasting_glucose | 8.3 | |
care_element | egfr | 78 | |
care_element | ldl_cholesterol | 3.0 | |
care_element | hba1c | 7.5 | |
care_element | smoking_status | never | |
care_element | bmi | 26.2 | |
care_element | diastolic_bp | 78 | |
care_element | systolic_bp | 121 | |
care_element | albumin_creatinine_ratio | 1.6 | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 128/80, BMI 35.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.4%, LDL 2.9 mmol/L, eGFR 77, ACR 1.5. Interpret in clinical context. | |
care_element | smoking_status | never | |
care_element | bmi | 25.2 | |
care_element | diastolic_bp | 77 | |
care_element | systolic_bp | 120 | |
care_element | albumin_creatinine_ratio | 1.5 | |
care_element | egfr | 77 | |
care_element | ldl_cholesterol | 2.9 | |
care_element | fasting_glucose | 8.2 | |
care_element | hba1c | 7.4 | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 127/79, BMI 34.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.3%, LDL 2.8 mmol/L, eGFR 76, ACR 1.4. Interpret in clinical context. | |
care_element | smoking_status | never | |
care_element | egfr | 76 | |
care_element | ldl_cholesterol | 2.8 | |
care_element | fasting_glucose | 8.1 | |
care_element | hba1c | 7.3 | |
care_element | systolic_bp | 119 | |
care_element | bmi | 24.2 | |
care_element | albumin_creatinine_ratio | 1.4 | |
care_element | diastolic_bp | 76 | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
appointment | Chronic disease follow-up | completed | |
note | SOAP note | S: Patient seen for longitudinal primary care follow-up. Reports variable home glucose readings and medication adherence questions, with no major interval concerns. O: BP 126/78, BMI 33.2, cardiopulmonary exam stable, feet checked when diab | |
report | Laboratory | Lab panel: HbA1c 7.2%, LDL 2.7 mmol/L, eGFR 75, ACR 1.3. Interpret in clinical context. | |
care_element | ldl_cholesterol | 2.7 | |
care_element | egfr | 75 | |
care_element | smoking_status | never | |
care_element | hba1c | 7.2 | |
care_element | fasting_glucose | 8.0 | |
care_element | albumin_creatinine_ratio | 1.3 | |
care_element | systolic_bp | 118 | |
care_element | diastolic_bp | 75 | |
care_element | bmi | 23.2 | |
appointment | Chronic disease follow-up | completed |
Lab panel: HbA1c 7.4%, LDL 2.9 mmol/L, eGFR 77, ACR 1.5. Interpret in clinical context.
124 mmHg
2026-01-13Diastolic Bp
68 mmHg
2026-01-13Bmi
29.2 kg/m2
2026-01-13Smoking Status
never
2026-01-13Hba1c
7.7 %
2025-12-12Fasting Glucose
8.5 mmol/L
2025-12-12Ldl Cholesterol
3.2 mmol/L
2025-12-12Egfr
80 mL/min/1.73m2
2025-12-12Albumin Creatinine Ratio
1.8 mg/mmol
2025-12-12Systolic Bp
123 mmHg
2025-12-12Diastolic Bp
80 mmHg
2025-12-12Bmi
28.2 kg/m2
2025-12-12Smoking Status
never
2025-12-12Hba1c
7.6 %
2024-11-11Fasting Glucose
8.4 mmol/L
2024-11-11Ldl Cholesterol
3.1 mmol/L
2024-11-11Egfr
79 mL/min/1.73m2
2024-11-11Albumin Creatinine Ratio
1.7 mg/mmol
2024-11-11Systolic Bp
122 mmHg
2024-11-11Diastolic Bp
79 mmHg
2024-11-11Bmi
27.2 kg/m2
2024-11-11Smoking Status
never
2024-11-11Hba1c
7.5 %
2023-10-10Fasting Glucose
8.3 mmol/L
2023-10-10Ldl Cholesterol
3 mmol/L
2023-10-10Egfr
78 mL/min/1.73m2
2023-10-10Albumin Creatinine Ratio
1.6 mg/mmol
2023-10-10Systolic Bp
121 mmHg
2023-10-10Diastolic Bp
78 mmHg
2023-10-10Bmi
26.2 kg/m2
2023-10-10Smoking Status
never
2023-10-10Hba1c
7.4 %
2022-09-09Fasting Glucose
8.2 mmol/L
2022-09-09Ldl Cholesterol
2.9 mmol/L
2022-09-09Egfr
77 mL/min/1.73m2
2022-09-09Albumin Creatinine Ratio
1.5 mg/mmol
2022-09-09Systolic Bp
120 mmHg
2022-09-09Diastolic Bp
77 mmHg
2022-09-09Bmi
25.2 kg/m2
2022-09-09Smoking Status
never
2022-09-09Hba1c
7.3 %
2021-08-08Fasting Glucose
8.1 mmol/L
2021-08-08Ldl Cholesterol
2.8 mmol/L
2021-08-08Egfr
76 mL/min/1.73m2
2021-08-08Albumin Creatinine Ratio
1.4 mg/mmol
2021-08-08Systolic Bp
119 mmHg
2021-08-08Diastolic Bp
76 mmHg
2021-08-08Bmi
24.2 kg/m2
2021-08-08Smoking Status
never
2021-08-08Hba1c
7.2 %
2020-07-07Fasting Glucose
8 mmol/L
2020-07-07Ldl Cholesterol
2.7 mmol/L
2020-07-07Egfr
75 mL/min/1.73m2
2020-07-07Albumin Creatinine Ratio
1.3 mg/mmol
2020-07-07Systolic Bp
118 mmHg
2020-07-07Diastolic Bp
75 mmHg
2020-07-07Bmi
23.2 kg/m2
2020-07-07Smoking Status
never
2020-07-07